In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
no speaker photo
Speaker
Milton Packer
Milton Packer Milton Packer

Baylor University Medical Center, Dallas (United States of America)

Specialities : Chronic Heart Failure , Acute Heart Failure, Pharmacology and Pharmacotherapy

30 presentations from this speaker

Conclusion.

Event : ESC Congress 2020

  • Session : New evidence on sodium-glucose transport protein 2 inhibitors therapy in heart failure patients
  • Speaker : M Packer (Dallas,US)
  • Organised by Charité IME, supported by Boehringer Ingelheim & Eli Lilly and Company Alliance in the form of an educational grant

EMPEROR-REDUCED Trial: main results.

Event : ESC Congress 2020

  • Session : New evidence on sodium-glucose transport protein 2 inhibitors therapy in heart failure patients
  • Speaker : M Packer (Dallas,US)
  • Organised by Charité IME, supported by Boehringer Ingelheim & Eli Lilly and Company Alliance in the form of an educational grant

Hot Line EMPEROR-Reduced.

Event : ESC Congress 2020

  • Session : Hot Line EMPEROR-Reduced
  • Speaker : B Casadei (Oxford,GB), R De Boer (Groningen,NL), M Packer (Dallas,US), M Metra (Brescia,IT)

Panel discussion

Event : ESC Congress 2020

  • Session : New evidence on sodium-glucose transport protein 2 inhibitors therapy in heart failure patients
  • Speaker : G Filippatos (Athens,GR), J Butler (Atlanta,US), M Packer (Dallas,US), S Anker (Berlin,DE), F Zannad (Vandoeuvre,FR)
  • Organised by Charité IME, supported by Boehringer Ingelheim & Eli Lilly and Company Alliance in the form of an educational grant

The future of pharmacologic treatment of heart failure.

Event : ESC Congress 2020

  • Session : New Trial Data in Hypertension and Heart Failure
  • Speaker : M Packer (Dallas,US)

Understanding and managing obesity-related HFpEF.

Event : Heart Failure 2019

  • Session : Reshaping the future of heart failure management - Translating innovations to practice in HFpEF
  • Speaker : M Packer (Dallas,US)
  • Organised by PACE-CME - Physicians' Academy for Cardiovascular Education, supported with educational grants provided by Novartis, Novo Nordisk and Pfizer

CANTOS – any word of caution?

Event : ESC Congress 2018

  • Session : CANTOS one year after – A critical review: inflammation and CAD prevention
  • Speaker : M Packer (Dallas,US)

Case1: my stable Heart Failure with reduced Ejection Fraction (HFrEF) patient: I should start an ARNI immediately!

Event : Heart Failure 2018

  • Session : Heart failure case debates with the experts
  • Speaker : M Packer (Dallas,US), S Anker (Berlin,DE)
  • Organised by Medscape Education, supported with an educational grant by Novartis

Catheter ablation is superior to drugs in the treatment of patients with atrial fibrillation and heart failure - CONTRA

Event : Heart Failure 2018

  • Session : GRAND DEBATE I - Drugs or interventions - The beat goes on
  • Speaker : M Packer (Dallas,US)

Discussant review - CANTOS.

Event : ESC Congress 2018

  • Session : Clinical Trial Updates
  • Speaker : M Packer (Dallas,US)

Examining heart failure cases with the experts: challenges faced.

Event : Heart Failure 2018

  • Session : Examining heart failure cases with the experts: challenges faced
  • Speaker : CS Lam (Singapore,SG), M Packer (Dallas,US), J Cleland (Glasgow,GB)
  • Sponsored by Novartis

Heart Failure 10 Years from Now - My predictions and how to get yourself ready.

Event : ESC Congress 2018

  • Session : Cardiology 10 years from now - My predictions and how to get yourself ready
  • Speaker : M Packer (Dallas,US)

Sacubitril - Valsartan should be the starting treatment in HFrEF patients - PRO

Event : ESC Congress 2018

  • Session : First-line therapies in heart failure with reduced ejection fraction (HFrEF) - ACE inhibitors or sacubitril/valsartan?
  • Speaker : M Packer (Dallas,US)
  • Great Debate

Sacubitril - Valsartan should be the starting treatment in HFrEF patients - Rebuttal PRO

Event : ESC Congress 2018

  • Session : First-line therapies in heart failure with reduced ejection fraction (HFrEF) - ACE inhibitors or sacubitril/valsartan?
  • Speaker : M Packer (Dallas,US)
  • Great Debate

What CABANA and CASTLE-AF do NOT tell us - A critical appraisal

Event : ESC Congress 2018

  • Session : Rhythm control therapy in atrial fibrillation - Influence of CASTLE-AF and CABANA on clinical practice in 2018
  • Speaker : M Packer (Dallas,US)

A TRUE tale of early vasodilator therapy in acute heart failure.

Event : Heart Failure 2017

  • Session : How the results of recent randomized clinical trials will impact our practice
  • Speaker : M Packer (Dallas,US)

Henry Krum lecture: what Henry Krum would have thought of the world of heart failure in 2017 .

Event : Heart Failure 2017

  • Session : Heart failure management: when the clinician needs advice
  • Speaker : M Packer (Dallas,US)

Vasodilators are useful in the treatment of acute heart failure - CON

Event : ESC Congress 2017

  • Session : Are vasodilators useful in the treatment of acute heart failure?
  • Speaker : M Packer (Dallas,US)

Vasodilators are useful in the treatment of acute heart failure - Rebuttal CON

Event : ESC Congress 2017

  • Session : Are vasodilators useful in the treatment of acute heart failure?
  • Speaker : M Packer (Dallas,US)

Vasodilators in acute heart failure: the end of the beginning.

Event : Heart Failure 2017

  • Session : Vasodilators in acute heart failure
  • Speaker : M Packer (Dallas,US)

Ularatide

Event : ESC Congress 2016

  • Session : New drugs in acute heart failure
  • Speaker : M Packer (Dallas,US)

From candoxatril to omapatrilat and LCZ696.

Event : ESC Congress 2015

  • Session : Natriuretric peptides as a therapeutic approach in chronic and acute heart failure
  • Speaker : M Packer (Dallas,US)

PARAMETER: Discussant review.

Event : ESC Congress 2015

  • Session : Hot Line IV - Hypertension
  • Speaker : M Packer (Dallas,US)

Angiotensin receptor neprilysin inhibitors.

Event : ESC Congress 2014

  • Session : Chronic heart failure treatment: what lies ahead
  • Speaker : M Packer (Dallas,US)

Dual function molecules in heart failure: what does the future hold?

Event : ESC Congress 2014

  • Session : Out with the old and in with the new in heart failure: new insights and new targets
  • Speaker : M Packer (Dallas,US)
  • Sponsored by Medscape / theheart.org

Panel.

Event : ESC Congress 2014

  • Session : PARADIGM-HF: The experts' discussion
  • Speaker : JJV McMurray (Glasgow,GB), M Packer (Dallas,US), K Fox (Edinburgh,GB), M Komajda (Paris,FR)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are